Takeda, Iambic sign multiyear R&D deal for AI drug discovery

Take­da has signed an­oth­er AI-fo­cused deal, this time fo­cus­ing on small mol­e­cules with the San Diego biotech Iambic.

The two an­nounced the mul­ti­year deal Mon­day …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.